pre-miRNA Information | |
---|---|
pre-miRNA | mmu-mir-466e |
Genomic Coordinates | chr2: 10479088 - 10479171 |
Synonyms | mmu-mir-466e, Mir466e |
Description | Mus musculus miR-466e stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |
---|---|
Mature miRNA | mmu-miR-466e-5p |
Sequence | 12| GAUGUGUGUGUACAUGUACAUA |33 |
Evidence | Experimental |
Experiments | Cloned |
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | Ubn2 | ||||||||||||||||||||
Synonyms | 2900060J04Rik, 6030408G03Rik, BC060116, D130059P03Rik, mKIAA2030 | ||||||||||||||||||||
Description | ubinuclein 2 | ||||||||||||||||||||
Transcript | NM_177185 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on Ubn2 | |||||||||||||||||||||
3'UTR of Ubn2 (miRNA target sites are highlighted) |
>Ubn2|NM_177185|3'UTR 1 CTTTCCAGCAAGGGGGAGAGGAACCACTTGGCTGGCTGGCGGGACCGACCTGATGGGAAGTCTTGGCGGTCACAGGGCTG 81 CTGTTTCTGTCCATGTTTACATGCTTGTCCCAAGCACTGTGGTGAGGAGGAAAAGAGAGAAAATGTTACTTGAGCAAAGC 161 CAGTGCAGGAGGAAGAGATGCTTTTGTGCAAAGTCAGGGAGCTTTGGTCTTTTCAAACCCAAGCCCCCATGTTAACCAAC 241 TTAAAGCAGACTCAGCTGTCAAACCCACAGAAGTGTCAATCTGACTGTATTTAAAAAAAAAAAAAAAAAAAAAGGAAAGA 321 AAAGAAAAGAAAAGGAAAAAAACTGGGGAAGAAGGAAGGAAGTTAAGAGGATTTGGGTAAATGGCCATCCATCCTGGGGG 401 TTAGGTCTGAACACTCTACAGATAAGTGCATAATAAAAGCAGCTACAAGTAGAATTAGCCCAGTTTAAGGAGACTCAGTC 481 ATGTCTGTCTAGTAGACAGATTTTCCACAGTCAGTTGCATGAGGCTCTCCAGACAGTTGCCGAAGAGTACTGTGCCCTGA 561 AATGTCCTGAGCAAACTTGAATCTTCTCCAGTATATAGCAGGTCCCCGTGCGAGTCAGTGGCCTGAAGATACTTTAGCAA 641 AGCTGCTGTGACACAGTGATGTGTAGTACTATAGCTTCTAGGTTTTTAAAGTCAGGAAAAGGAGCCTGTGCTCTTACGAG 721 ACAAAATGTAGATAATCCCTTTTTATAAAAGGGTCAGTTTCACCCTCCATTCAGAAGTAAGTACTGCACTCCTTTCCACA 801 GTTCACTTGTCATCTGGTATTGACTGGTTAATAGTTATTTCTCGTCCTGATATGCAGAAGTGACTGCTCGCATTTTCTCT 881 TGACATGTGCGTCTTTGTTGTTGGGCTGCTGCTTTGCTGCTCATCTCTCTTGCAGCCTGCCAAGAACTGCAAACTCCCAG 961 TTCCCTCCCTGCACAGTGCTCTTTCACTAGCGGTACTTTAGGTGACTAGAGCTGTTGATATAAACAGGAGTGTGCACAGC 1041 ATCTGTCTCTTCATGGGTCAAACAAATAGCGTATGTATAATAGTGGACTGTTTTTCATTCTGAAGTGGTATTTTTAAAGG 1121 GATGAAGTCTAATAGGAATACGGATGTGCACAGGATGTGCACAAAGGACCACCTGTTATAACTATCACAATGAAGCTTTA 1201 TGACCCATGCCCAGCGCAGGATGTTTTCAGCATTTGGGATCTTAAAAGTTTTACTATGACTTACTCAGAATATTAATATT 1281 CAAGTCAGCCTACAGATTATAAGATTCGTTAATTCTAGTTTTCATATGCGAATAGAGGCAATGAAGGGTGTGAAGGGGAA 1361 AACACAATTTTCTTGGGATACATTTTATTTTGCCTCAGCTATGTTTGTGGTGTCCTTGAATTTTAAACTTCTGAGTATTT 1441 TCAGACTATCCAAGAAAAAGCTCTGAGTGATACAAATTTAGTTTATATATGGTGACAGACTAGCCTGGTAATAACAAGAT 1521 TGCTTCTATAATCTCATTACATATTACTCTGTATCATTTAAGTTTATTCAGATAAGAGTGTTAACCAGACCCCATTTTCC 1601 TTTGATGAGCAAAAGTCCCAAGAAGCCTCTAGGACTATAATAACCAACCGCAGACCTGCTCCAATTTTTATGCCTATAAT 1681 TTGACTTCAAAGTTTCAATGGCGTGCTTAATAGCAAAAAAGTCAATGAATAATTGAAAGCTTTAGTTCCAAGAACTCGTT 1761 ACAGTAAAGGAAGATGATTTTTTTTTTAGAAGAACATTGAAACTAGATATGATGGCCCATGCTTGTAATCCTAGAATTCA 1841 GGAAGCTGAGGCAGGAAGATCTCAGGTTTGAGGCCAGCCTGAAGTATTTAGCAGCAAGTCCCATGCTAGTCTCTACTGGA 1921 CTAACAATGAGAGCTGTCTGTTTCCAACTGTCTTATTGTCTTTTAATGTTCAATTAATTAAAAATCTATTGGACTTCCAT 2001 ATCAGGTGTCCCTGACAGCAAGTTCTTCAATGTCACTTGCTGCCATATGAAAATAATCTTTAAAAAGTTCATAAAGTTCT 2081 TCAAAAAACTGGGGCCCCTTGCTCCAGGCTCCTTCGCGCCTCTTCTCCTTCCGGTTTGGTGCAGAATGGGTTGTGAGCTG 2161 TGTTTTTTTCTTTTTGTCCTCTTTTGTTACTAACATTTTTCTTTTTCTTTTTTTCCTTTTTCTTTTTTAAAATAAAAAGC 2241 ATAGATTTCCCCTCCTTACCCCTCCTTTTACAATGGTCTCTTCTCCGCTCTAAGTCCTCCCACTTCCTAGTTCAAGTTTC 2321 ATTTGTGCCCCGACTGCCCCCCTCCCTGCCCCATTGCATTGTTTGTGTGCGGCACCTGCAGTAGAAAATCCCAGCTCTCC 2401 AGGTCGGTCTGGGAGCTCCTCCACCCTCCTCCTGTCTCAAAAAAGAAAAAGAAAAAAAAAGAGAGAGAAAAGAAAAAAGG 2481 AAAACAAACGAAAGTAATCACTGATATAATTTCTTGACTGTAGAAATTTACTTTACCAATAAAACAAATGAGGAGGCTAT 2561 GTAAGCCCCAGTAGATATTTTGGAAAGATATTGGGATGTTGCAGAGAAGTTTGACTTGAATTTAGCACGTTAAGGTTCAT 2641 TTGAAAGGTCTCTTAGAGAAACTTGATCAGCTCTTACGCCAGCACCAGGAAACTTCGTTTCACAGGCCTGCTTATACTTC 2721 ATAAATTGCTGTACTGGGGTGTCTGTTGAGGAAGGCAGCCTGTACTTCATTTTCTCTACCCAGAGAGAAGTCCATGTGTG 2801 TTAGTGTCTCTTCTTGCTGATACTTGTGTATTTGTGTATTTGCAGACACATACATATTCATATAAATCAATCGATATTAA 2881 AAGTCAAACAATAATTGTAGGTTCTTAAATCCATCGATTCTGAACCATGCTATACGAAGACCCTTGATGGTTCTCTTTCC 2961 CATGTCATTTTATAAGATTACCCTGGGCTCTGAGACTATGCTGTGTAAAATATATCCTGTTTTCTGTCAGTCTTGACTCC 3041 TTAAGGACTGCTGCCAGATCCCCAGTCCAGCAACCCTTTCATGTTATACAAGTGAATCAAAGTCCTTTCTAAATGTAAAT 3121 ACATTTCTTTCTATATCATAACATTGAAAATGGTGTCCATACTTTATGGTTACCTGTCTTTACAGTTTTTATTACTAAAC 3201 AAGCATATAAGTTGGTTATTTTTTAACAGAGACTTGCAATTCATACTGTATTTTTGCACTTAAAGTCAAATTATGTTATT 3281 TTTAAAATGGTGAATAACTGGAAAGGATATCTATAGAGCAGTGTGTATCACTAAAGAACGTTAGCAACATCCAAATGCAG 3361 AAGTAAATCAGCACACGTAGGTCCCATTCGATGGGGTCCTTGATTCAGGAATATTAAACTGTCTGTTTCCAACTGTCTTA 3441 TCTTTGAAATTGCCTTCACTGATGTGATGTCTAAGCTGTTACTGTATATAAAGGTGATCCTCAGTATTCACAAGCAATAA 3521 CAGTCAGCAGCGCTGTCCTCGGGCAGCAGTGCTGGACCACAGCTGGAGACTGTTTGCGAGCCAAGTGTCATGCTCACTCA 3601 GAGCCTCCAAAGTAAATGCAAGCAATAATCTCTACTAAAATCAAATTATAGTTCTTCTCCTGCTTCTGAGAACAAAGAGT 3681 GAAAATCATGATTTTAAAACAATCTGGAGAAAAGGTTTGGAGAAAAGAAGCCAAGTTAATGTATAATAACAAAGTCCTGA 3761 TATTTTGAAGAAATCAAGAAGATTCAATTAGTACATTCTTTCATGCCCACCACCCCTTTGATGGATGTTATTAGCCCAAA 3841 TTATCTTGTTTTGTGTCATAAACAATAAATAAGGCTTATTTGGGTCCCAGCACTGGGGAAAGAACTGGGCATATACCTGT 3921 GGGTATATATTGACTGTGGGTTTGACACCTGCTTGGAAACAGCTTATTGAAAGTGATCTTAATCCAGAATATTTTTTCCC 4001 AAAGCAGATCTAAATTGTTTACTATGCAGAGATGGAAAGGGTAGGCACCCCTATTCTCTCTCCTCTTGTTGTCCTCTCCC 4081 ACAGCCCTTCCCACCTCTCCTTGATTCAAGACTTTCTAAAATGAAAATCCTACTGTTATTGCGACTGCCATTGGTTATGA 4161 GAACTCTGTTCTTTGGGAATGTCTCTAGAACTCATTGTCCTACTTGCTGCTACATTGGAAGATGATCTTTGCCTGTGTTG 4241 GCTGACTTTAACTGCTTTATTTGTAGGAGACTTTGTCATGTCCTTTGACCCTGTGTAGAAGAACTAGGGTACTTTACTTT 4321 AGGAGTGTACTATAAAAGCACACTGGTCCTCGTATTGTTAGAGAAGTTTGGGATTTGTTCCCCTTGTTGGTTTTTGTTTT 4401 GTTTTATTTTTCAAATTGAAAGTAGAAGAAAGAAGTCTATAGTCCAGGCCGGACTTGAGCACTGCCCTGTGCTTCAGCAC 4481 GGTGCTTCTGCTGACCCACGTTCTCTGAAGGGCACTTTGATTTCTAGTTGTGCATGTGCGGCTCTTTGTTTGGTTTTGCT 4561 TTCAGGGTGCTTTTGGTTTTGTAAAAACAAAGCAGAGAAAAGTACAGTAGTAGATAAATGATCACAAACATGTTATGCAA 4641 TTTTATTTTATAAAGTTTTAAGGGAAAAGTTTATCTCGTTGTAAATAAGTTCTTATCTCTGGTAAAATGCTTATATTACT 4721 CCTCTAAACCATGCTCAATTCAGGCCTTTGTCTTTGTTAAGTGCCTTTTATTTCTTTCTTTTTCTCCCTCTTTTGAAACT 4801 TTCAAACACCCTCAAGTACAGACTGATGAAGTCAGGGGATTCAGGAGAAAGAATCTGAGCCTTGCCAAAATCATGTCATG 4881 TAATAATTCTCTTCCTTCTGCTTTGTGTGTGTGGACACAAGTATGAGGTACACAGCGTGTATGAAACCAGGAGCAGCTGT 4961 GCCATGGCAATCCTTCTAAGCACTGCCCTGTTGACATTGCAGAACTTCTGCCTTGTTTATTCCATTGCTTTGAGTTGATT 5041 CAGATGGGCAGATTGGGAAGTAGTCTTTGCACATGATGCTGGCTTCCCTTTCTGAATATCTGTAGAAGTTAATATATATG 5121 TGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTATATATATATATATGTAGGGCATTATATATATAAAGCAT 5201 ATGTGTTGGTTATTGCAAACATAATAAACTCTGTGGACTCCTTGACTATTTCTGGATGTAATCCACTTCTCTCTACCCCT 5281 CAAATCTTTCAGTAGTAGTGTGTGAGAAAGCATCAGGATAACAAGAGCATTTGTTGGTCGAGGTGATACGATGCCCTATG 5361 CAGACAAGATTCAGTACTAGTGCTAGAACCATGGGGTGGTGTCTGAATACACTTTGGAGGAGGTTGGCACTCATGTCAAT 5441 ATTAAAAGACGTTTTCTTCTGGAAAATGATCTTGAAATTGTATATCTGAAACGTCAATAAACTTAGATTTTTAGACAGTG 5521 AGGAAACACTTGTATAATCAGGACGTACTTGAGAAATGTTCAGTCTGTTTATTGCCAGATGATCAGATTTGCTCTGATTT 5601 CATGATTGTTTAAATGTCTTTCCTGAGCAAAATAAAATAACTTTCAGTATCTAAGACTTGAGGGGGGGGTTCTGTTTTGT 5681 TTTTGTTTTTAGATGTAACATGTTGAAAAAGACTAAGTTGAACTGATCCTCTGTATATCTACAAAGGACCCCCTTTTAAG 5761 TAAAATTTTAGTTGAAAAAGGAGACTTGTGGCTAAAAGAAGAGGTTCCTGTAGCAAAGCTGTTGTTAGCCAGCTTAGGAT 5841 CAGTAGTGAGTGTTAATTCCTAAACTACTTTATCTAGGGGGAAGTCATTTAACCTTTGTGCCTCAGATTACCCATGAGAC 5921 AATTGGGTATAATAATAATCACCTACCTCCCAGGGATATCAGAGACTTTACTATTTCAAAAATATTTTGTTTTTCTAAAA 6001 CATTCTATATAATTATAGTATTATCTTCCTGCAGAGGTTGAAAAAAACAAATGTTTTTCTTATAGTGGATATAAAGAGCA 6081 CCCTATGGTCTTTAAGTTAAAAAAAATCACTGGAATTTTAATTTAGATGTATATTTGATATTTAAACATACCATATTTGT 6161 TGTGTGGTATAATTATTAGTTTCAGATTAAATCAAAGGGGAATGAACACTAAGTTTCTTAACTATCAATAGATTTTTTAA 6241 AGCTTTTATGATGTTATTACTTGTGTGATATTTGCAAAGGTTGTGAAAGTAAAGTTAGATAAAGTTTGAATTATGGATAA 6321 ATGATCCTGAAAGTTTATAGCCTCCTTTGTCTACATTCTGAATCTAATTTCCTTGCAGTACTTGCCTGGTGATGGAAAAC 6401 TAATTTTTTACCTTTCTAAGAGTAAGTCAGATCCTGGCATACGACTCCTGCATCAGTAGGACTCTCCACCTTTGCCTGGG 6481 GGATAAGGCATGAGCAGCCTACACTAGGGCGGCTGTGCGTTCTTTTAACTTTGTATTTCATGCTTCTTCAGCCAGAGCCA 6561 TCAACTGTTCGGGTTGTAGTAAAATGGGAGGAAGATCGACAGGATTCACTCCCTAGCTAGGGCAGAGGTAAAGATGGTCA 6641 GGATAGAAGGAAATATGATTTCCCAAACTCCTGGGAGGAAATTAGCATCATTTTATCTTCCCCTCCAGGCATGCACACTA 6721 AGTAGTAATCCATAACATTTTTCTCTTTAAAACGATAACAACAGGAACAAATGGGTACTACAGTTTTTGTTAGGGCTGAG 6801 TAGTGCATGTGAGAGTGGGGGCGGGAGGGGGGTAGTCTAAATGACAGCGAATATTCAGGGTCAGAGAGAGTGGAGTGCAG 6881 GGTGTTGAGGAGCAATTACTCAGCTCAGGTGAGTTAGGAGGTAGCACTGGGCTGAAGCAGCCAGCACATCTGGGCTGACC 6961 CAGAACTGGCTCAGACCTAGTCATTCTCTAGTCCTTCTAAAATCATTTTTGGGATTTTTGTTGATTTTTTTTTCTCTCCA 7041 GTAGCCTCTGAATATCAGCTATGCAGATAAGCATATGCTTCGTTTTCCACATTATATTCCTATTCATTGTTCAATAACAT 7121 GTTAAGATTAACCCAAATGAATGTGTGTGTTTCCTCTAGAGAAGAGTAACAGAAGCCTAAAATAAATATCATCTGTTTTC 7201 CTTTGCCCTAAAATGTGAACTTTCCATAAAACGCTAGCTGAAGATCCTTTGCTCATGCAGACCTAGAGTTGATGTTATGG 7281 ATGTGTTTGCACTTTTATGATAGTGTCACCTCGTGTAATGCTGAGAGGCTTAGGTTAGTGTTCAGGATGACAGAGCTGCA 7361 GACTTGGGCTCTGATTAAAATTAGTTTCAAATATCAATGTTGAATTTGTCTTCATTTCTTTCAGTCTTCAGTCTTGCCTT 7441 TGGTGTGAGCTCTTAAGTTCCCACTTGCTCCACTACAGTATAAATTACCTGTTGTTATATCTAGGGAGAGAAAGTGAATT 7521 GTTTCCATATCCTCTTCTCCCTTACTTTGCCATCTGCTCTCAGTTCCCATCAAGTTAGTGTAAAGATAGTGTGGGGAGAG 7601 TTTCATCTTAGTGGAGGATACATATATATATAGAGAGAGTTTAGTGGAAATACCTTTGAGTAGCCTGATGCTAAATGACA 7681 CTTTTCTTATGCACACTCAACGTACCATTTGCTTTAAGGTGGCTATTTGTGATCTCCTTGTGTTGTGATGTTTCTACTTG 7761 TCTGTCTTTCCTATGTATTTCCATTTCATAGCAGCTAGTATTCAAACTTTGTATACATTTTACACTGCTACCCAAACTAG 7841 TCAGTGACGTGTTTTGAAGTTTTCATGGTACAAATTAAGGTTCTATACATAGTGTAGAACTTGGTGGTCACTGATGACTG 7921 GGGTTTCTTCTCTTTTCATTTATATTCAATAAATAAATAGATTTCATAGGCTGAGAGTCTGTCTCACTGGGCACTCTTGC 8001 CCAGCATGTACGTAAGCTAGAGCTCCACACAGCAGTGCACAGTAACAGTAAGTAGACTTCATTTTTACATAGCCTGGGAT 8081 ACCAGTGTATTTTACATAGCCTGGGATACCAGTGTATTTTACATAGCCTGGGATACCAGTGTATTTTACATAGCCTGGGA 8161 TACCAGTGTATTTTAAGATTCTTCAGAAGAAATGCAGATTTTCATTAGGGGCTCACAGCAGTCTGCCTTGCTGACTGTTT 8241 TCATACAGACTCCTTACAACAGAGCTCTTTTGCCAAGGTCTGAGCCAACCAGATCATTGAATCCTAGTTAGGACCTAAGT 8321 CCTAATTTTAGGTTCCTCAAAAGAAAAACATTACTTGCCCCGACTTTGCTACAATATTCTGGATTTGTTTGTTTGTTTGT 8401 TTGCTAAATCTGGTTGTTAGATCCTTGTTAATAGTGCTCTGGTTAGAATTCAGTTAAGGTTATTTGTCTGAGATAACACG 8481 AGAGTCAGCAGCAGTCCAGACTAGCCACTGTGTGTGTGATAATCTGTGCTGAAGTTTCCACACCAGATTGTATTTTCTGT 8561 ACTTAGAACCATAGACTTTCCTCCTGTTATACTTATCTCTGCTGTTTACAGAAACGTTATGCCCTACTAGAAAATTCACT 8641 AGCAAAATTACCAAGGATTTGCCCCCATTTGGGCTAGAAATATAAAAAGAAAAAAAATATTTTTCTTAGTTGACAAAAGT 8721 ATTTGGTTTAAATAGTTAGAAAGTTGAGCCAGCTTTGGTCAGTTTTCCTGGCATTTTGGCTCTGACTCCATCATAGATTG 8801 CGTGTACACTTTGACATGTGTTCATCAGGGACCCTCTCCCAGTAAAGATTGGTTTTCCTCCCACACAGCTTTCAGGACAG 8881 AGAGCCAAGCTTTTCAGTGACCTGTTTTCAGCTGTCTTTGAAAGACTATCTTATTCTAGAAAATGCTGGCGTGCTAAACT 8961 GTTCTTGGAAGAGAGTGTGCTAGTTTGACCCTCCTCATGGTGTCTCTTGTCCTGTTAAACTTATCAGACTTCAAGGAAAG 9041 GAAGAGAAATCTCTGGTGAATTTTGTGCCCCAAATAATGAACTTAAGTCTAACCAAGGTGACTAAGAGATGGGTGTTTTC 9121 TCTCTCTACTCGTGAGCAAGGTTTATTTATGGTTGTAAGACTTACCATGGAACTGCAGACCTATTTGCCCAGAAAATAAG 9201 AGTCAGAATTTTAGTCATGTTAAGCACAGATTTCGAACCCTTTGGTAAAGTTAGATAAGGGGAGACTTTTGTTTAGTAGC 9281 AGAAGGAAAAATAATTATTTATACAGTGAGTATCCACCCTGCAAAGCCACTTCCCAGTATGGAAGCAGCTCCTCTTTAGT 9361 CCCTTCTGCCCTACACAGATGCTACCATGTTTGCAAGCCAGTCTCCAAGAAGGAGCCGAGGAGTTGATGGTCCTTTAGAG 9441 GAGAGGCCTCAGTTACTGGGTTGCATCTGCTTGTAGGAAAGTGTGTTTGCTAACTTGAAGGAATATATGCTGTACTTCAA 9521 ATAAGTGTGTGACTTAATGCTTTGGGATTTTTTTTCCCTCTAAAACTGGACCTGAACACAGCTTTGAGTTGGTATTTGTA 9601 ATAATCTCAGGACCCGAAAGATTGTAGCATTTAGTGTGTCTTAAAAATTATGTACTGTACCAGCCATGGAGTTTTGTAAA 9681 TATACCTGTCTCCCTTTTTTTGTATTATTTTAGTAAACAATAAATAAATAAATAAATTTAATAAAAGGGGGTGATGATGA 9761 TGTGTGTGTTTGTGTGTGTGTGTGACTGACTCTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGGCTCTTTTGGAGGCAA 9841 ACTGGTGCTTGTTGAATTTCTAGTTCAGTTCAGCAGGAATATAGACAAACTGCTGCTGTTGACCCTTACAATGAGCAAGG 9921 AGGAGGTCCTTCATTTTGCCCTCTGGTGGTTCATGTAGTACTAGCAAAATGGAAGTCAGGAGCTAAACTCTTCTCCTCTG 10001 GCCATATTGCCTTTGTGTTCTTGGTCTAGCTCCAACATTCTTTGACCTCTGGCATTAAAGCTTCCACACTTTGAAGATTC 10081 CTGGTTTTAGAGCTCTTAAAACTTTCCTAAGAGAGAGAGAGAGAGAAAAAGGGGGGGCTGATTATAAAATAAATAAAAAG 10161 CAACAAAAGAGCCTCACATTTCATAGGACCGCTGGTGAATTTTAGATATTTCCAAACATGCATCTGAGAACTTATTAAAC 10241 TAGCCCCACAGTGCACTCCTCAGTGCGGGGATGTCTGTGTTCATTTTGCTTTGCGACAGCCTTGTTCATATTCCAGGTGT 10321 AACTAGCAAACCTGTTTTAAAATGAGAGCCTTATTCGATTCAGTGTAGATGTTTCCTGGCTATCCTCCAAGACAGGACCT 10401 TTTTACATGAGTGAGTTTTTCTTTTTGTATATGTTAATGTGTTTGTTGTATTAAATAAAGAGGAATGTAAATATTAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
Experimental Support 1 for Functional miRNA-Target Interaction | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
miRNA:Target | ---- | |||||||||
Validation Method |
|
|||||||||
Conditions | C2C12 | |||||||||
Location of target site | 3'UTR | |||||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | |||||||||
Original Description (Extracted from the article) |
...
HITS-CLIP data was present in GSM1385343. RNA binding protein: 聽AGO2. Condition:C2C12_DM_Ago2_CLIP-Seq_myotubes
... - Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al., 2014, Cell. |
|||||||||
miRNA-target interactions (Provided by authors) |
|
|||||||||
Article |
- Zhang X; Zuo X; Yang B; Li Z; Xue Y; Zhou et al. - Cell, 2014
MicroRNAs are well known to mediate translational repression and mRNA degradation in the cytoplasm. Various microRNAs have also been detected in membrane-compartmentalized organelles, but the functional significance has remained elusive. Here, we report that miR-1, a microRNA specifically induced during myogenesis, efficiently enters the mitochondria where it unexpectedly stimulates, rather than represses, the translation of specific mitochondrial genome-encoded transcripts. We show that this positive effect requires specific miR:mRNA base-pairing and Ago2, but not its functional partner GW182, which is excluded from the mitochondria. We provide evidence for the direct action of Ago2 in mitochondrial translation by crosslinking immunoprecipitation coupled with deep sequencing (CLIP-seq), functional rescue with mitochondria-targeted Ago2, and selective inhibition of the microRNA machinery in the cytoplasm. These findings unveil a positive function of microRNA in mitochondrial translation and suggest a highly coordinated myogenic program via miR-1-mediated translational stimulation in the mitochondria and repression in the cytoplasm.
LinkOut: [PMID: 25083871]
|
CLIP-seq Support 1 for dataset GSM4751762 | |
---|---|
Method / RBP | HITS-CLIP / AGO |
Cell line / Condition | adipose tissue / RNA sequencing of eWAT 3 |
Location of target site | NM_177185 | 3UTR | CACAUACAUAUUCAU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Accession Series | GSE142677 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM1385343 | |
---|---|
Method / RBP | HITS-CLIP / AGO2 |
Cell line / Condition | C2C12 / C2C12_DM_Ago2_CLIP-Seq_myotubes |
Location of target site | NM_177185 | 3UTR | UGAUACUUGUGUAUUUGUGUAUUUGCAGACA |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 25083871 / GSE57596 |
CLIP-seq Viewer | Link |
145 mmu-miR-466e-5p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT410978 | Ado | 2-aminoethanethiol (cysteamine) dioxygenase | 2 | 2 | ||||||||
MIRT417624 | Lifr | leukemia inhibitory factor receptor | 2 | 2 | ||||||||
MIRT432330 | Igf2 | insulin-like growth factor 2 | 2 | 4 | ||||||||
MIRT577332 | Zfp157 | zinc finger protein 157 | 2 | 2 | ||||||||
MIRT577683 | Slc39a14 | solute carrier family 39 (zinc transporter), member 14 | 2 | 6 | ||||||||
MIRT577854 | Rassf5 | Ras association (RalGDS/AF-6) domain family member 5 | 2 | 2 | ||||||||
MIRT578123 | Nqo2 | N-ribosyldihydronicotinamide quinone reductase 2 | 2 | 2 | ||||||||
MIRT578174 | Neu1 | neuraminidase 1 | 2 | 2 | ||||||||
MIRT578293 | Mavs | mitochondrial antiviral signaling protein | 2 | 2 | ||||||||
MIRT578540 | Htr1f | 5-hydroxytryptamine (serotonin) receptor 1F | 2 | 2 | ||||||||
MIRT578635 | Gtf2h2 | general transcription factor II H, polypeptide 2 | 2 | 2 | ||||||||
MIRT578659 | Gramd1c | GRAM domain containing 1C | 2 | 2 | ||||||||
MIRT578883 | Fam107a | family with sequence similarity 107, member A | 2 | 6 | ||||||||
MIRT578911 | Entpd1 | ectonucleoside triphosphate diphosphohydrolase 1 | 2 | 2 | ||||||||
MIRT579075 | Cox15 | cytochrome c oxidase assembly protein 15 | 2 | 4 | ||||||||
MIRT579095 | Cnih3 | cornichon family AMPA receptor auxiliary protein 3 | 2 | 4 | ||||||||
MIRT579133 | Chrna1 | cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) | 2 | 2 | ||||||||
MIRT579301 | BC021785 | major facilitator superfamily domain containing 4B5 | 2 | 2 | ||||||||
MIRT579361 | Aplnr | apelin receptor | 2 | 2 | ||||||||
MIRT580013 | Whsc1l1 | nuclear receptor binding SET domain protein 3 | 2 | 4 | ||||||||
MIRT580126 | Ubn2 | ubinuclein 2 | 2 | 2 | ||||||||
MIRT580259 | Trim12c | tripartite motif-containing 12C | 2 | 2 | ||||||||
MIRT580358 | Tmem26 | transmembrane protein 26 | 2 | 2 | ||||||||
MIRT580397 | Tmem170b | transmembrane protein 170B | 2 | 2 | ||||||||
MIRT580836 | Smarca2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2 | 2 | 2 | ||||||||
MIRT581003 | Six4 | sine oculis-related homeobox 4 | 2 | 2 | ||||||||
MIRT581112 | Sept3 | septin 3 | 2 | 2 | ||||||||
MIRT581333 | Rgs8 | regulator of G-protein signaling 8 | 2 | 2 | ||||||||
MIRT581426 | Rasal2 | RAS protein activator like 2 | 2 | 2 | ||||||||
MIRT581434 | Rasa2 | RAS p21 protein activator 2 | 2 | 2 | ||||||||
MIRT581473 | Rabgap1 | RAB GTPase activating protein 1 | 2 | 2 | ||||||||
MIRT581601 | Prkcd | protein kinase C, delta | 2 | 2 | ||||||||
MIRT581808 | Plag1 | pleiomorphic adenoma gene 1 | 2 | 2 | ||||||||
MIRT581914 | Pgm3 | phosphoglucomutase 3 | 2 | 2 | ||||||||
MIRT582069 | Onecut2 | one cut domain, family member 2 | 2 | 2 | ||||||||
MIRT582600 | Lrrc40 | leucine rich repeat containing 40 | 2 | 2 | ||||||||
MIRT582752 | Klf8 | Kruppel-like factor 8 | 2 | 2 | ||||||||
MIRT583022 | Htt | huntingtin | 2 | 2 | ||||||||
MIRT583260 | Gnb4 | guanine nucleotide binding protein (G protein), beta 4 | 2 | 4 | ||||||||
MIRT583313 | Gfod1 | glucose-fructose oxidoreductase domain containing 1 | 2 | 2 | ||||||||
MIRT583618 | Fam46a | family with sequence similarity 46, member A | 2 | 2 | ||||||||
MIRT583813 | Eif2s1 | eukaryotic translation initiation factor 2, subunit 1 alpha | 2 | 2 | ||||||||
MIRT583908 | Drp2 | dystrophin related protein 2 | 2 | 2 | ||||||||
MIRT584442 | Ccdc85a | coiled-coil domain containing 85A | 2 | 2 | ||||||||
MIRT584656 | B4galt6 | UDP-Gal:betaGlcNAc beta 1,4-galactosyltransferase, polypeptide 6 | 2 | 2 | ||||||||
MIRT584859 | Appl1 | adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | 2 | 2 | ||||||||
MIRT584912 | Akap10 | A kinase (PRKA) anchor protein 10 | 2 | 2 | ||||||||
MIRT585294 | Zfp26 | zinc finger protein 26 | 2 | 2 | ||||||||
MIRT585429 | Wars2 | tryptophanyl tRNA synthetase 2 (mitochondrial) | 2 | 2 | ||||||||
MIRT585487 | Txlnb | taxilin beta | 2 | 2 | ||||||||
MIRT585694 | Tbc1d24 | TBC1 domain family, member 24 | 2 | 2 | ||||||||
MIRT585739 | Steap2 | six transmembrane epithelial antigen of prostate 2 | 2 | 2 | ||||||||
MIRT585878 | Slc22a8 | solute carrier family 22 (organic anion transporter), member 8 | 2 | 8 | ||||||||
MIRT585907 | Slc17a5 | solute carrier family 17 (anion/sugar transporter), member 5 | 2 | 2 | ||||||||
MIRT585960 | Sike1 | suppressor of IKBKE 1 | 2 | 6 | ||||||||
MIRT586177 | Ptprr | protein tyrosine phosphatase, receptor type, R | 2 | 2 | ||||||||
MIRT586589 | Mrgpre | MAS-related GPR, member E | 2 | 2 | ||||||||
MIRT586806 | Ints8 | integrator complex subunit 8 | 2 | 2 | ||||||||
MIRT586919 | Heatr2 | dynein, axonemal assembly factor 5 | 2 | 4 | ||||||||
MIRT586945 | Gstt3 | glutathione S-transferase, theta 3 | 2 | 2 | ||||||||
MIRT587123 | Gfpt1 | glutamine fructose-6-phosphate transaminase 1 | 2 | 2 | ||||||||
MIRT587151 | Gcnt4 | glucosaminyl (N-acetyl) transferase 4, core 2 (beta-1,6-N-acetylglucosaminyltransferase) | 2 | 2 | ||||||||
MIRT587239 | Nxpe3 | neurexophilin and PC-esterase domain family, member 3 | 1 | 1 | ||||||||
MIRT587482 | D630045J12Rik | RIKEN cDNA D630045J12 gene | 2 | 8 | ||||||||
MIRT587489 | D630003M21Rik | RIKEN cDNA D630003M21 gene | 2 | 2 | ||||||||
MIRT587602 | Cml2 | N-acetyltransferase 8 (GCN5-related) family member 2 | 2 | 2 | ||||||||
MIRT587664 | Cdk7 | cyclin-dependent kinase 7 | 2 | 2 | ||||||||
MIRT587741 | Cd28 | CD28 antigen | 2 | 2 | ||||||||
MIRT587752 | Cd200r1 | CD200 receptor 1 | 2 | 2 | ||||||||
MIRT587775 | Ccpg1 | cell cycle progression 1 | 2 | 2 | ||||||||
MIRT587839 | Casp8 | caspase 8 | 2 | 4 | ||||||||
MIRT587959 | Asah2 | N-acylsphingosine amidohydrolase 2 | 2 | 2 | ||||||||
MIRT588288 | 1700019G17Rik | N-acetyltransferase 8 (GCN5-related) family member 4 | 2 | 2 | ||||||||
MIRT588355 | Zfp518b | zinc finger protein 518B | 2 | 2 | ||||||||
MIRT588392 | Zeb2 | zinc finger E-box binding homeobox 2 | 2 | 2 | ||||||||
MIRT588548 | Uhrf1bp1l | UHRF1 (ICBP90) binding protein 1-like | 2 | 2 | ||||||||
MIRT588604 | Tsc22d3 | TSC22 domain family, member 3 | 2 | 2 | ||||||||
MIRT588726 | Tbx22 | T-box 22 | 2 | 2 | ||||||||
MIRT588954 | Scn2a1 | sodium channel, voltage-gated, type II, alpha | 2 | 2 | ||||||||
MIRT589780 | Insig2 | insulin induced gene 2 | 2 | 4 | ||||||||
MIRT589840 | Hif1an | hypoxia-inducible factor 1, alpha subunit inhibitor | 2 | 2 | ||||||||
MIRT589863 | Hecw1 | HECT, C2 and WW domain containing E3 ubiquitin protein ligase 1 | 2 | 2 | ||||||||
MIRT589975 | Gabpb2 | GA repeat binding protein, beta 2 | 2 | 2 | ||||||||
MIRT590188 | Ell2 | elongation factor RNA polymerase II 2 | 2 | 2 | ||||||||
MIRT590360 | Clca2 | chloride channel accessory 3A2 | 2 | 2 | ||||||||
MIRT590488 | Calcoco1 | calcium binding and coiled coil domain 1 | 2 | 2 | ||||||||
MIRT590659 | Apba1 | amyloid beta (A4) precursor protein binding, family A, member 1 | 2 | 2 | ||||||||
MIRT590843 | Wdr46 | WD repeat domain 46 | 2 | 2 | ||||||||
MIRT590859 | Vps33b | vacuolar protein sorting 33B | 2 | 4 | ||||||||
MIRT590920 | Tacr2 | tachykinin receptor 2 | 2 | 2 | ||||||||
MIRT590936 | Supt7l | suppressor of Ty 7-like | 2 | 2 | ||||||||
MIRT591004 | Sh2d2a | SH2 domain containing 2A | 2 | 2 | ||||||||
MIRT591018 | Scd3 | stearoyl-coenzyme A desaturase 3 | 2 | 2 | ||||||||
MIRT591037 | Rfx3 | regulatory factor X, 3 (influences HLA class II expression) | 2 | 2 | ||||||||
MIRT591045 | Rassf2 | Ras association (RalGDS/AF-6) domain family member 2 | 2 | 2 | ||||||||
MIRT591136 | Nsun3 | NOL1/NOP2/Sun domain family member 3 | 2 | 2 | ||||||||
MIRT591225 | Ly96 | lymphocyte antigen 96 | 2 | 2 | ||||||||
MIRT591308 | Il18r1 | interleukin 18 receptor 1 | 2 | 2 | ||||||||
MIRT591349 | Flrt1 | fibronectin leucine rich transmembrane protein 1 | 2 | 2 | ||||||||
MIRT591363 | Egfl6 | EGF-like-domain, multiple 6 | 2 | 2 | ||||||||
MIRT591410 | Cer1 | cerberus 1, DAN family BMP antagonist | 2 | 2 | ||||||||
MIRT591443 | Bcl2 | B cell leukemia/lymphoma 2 | 2 | 2 | ||||||||
MIRT591521 | Abcc9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | 2 | 2 | ||||||||
MIRT591577 | Zfhx3 | zinc finger homeobox 3 | 2 | 4 | ||||||||
MIRT591597 | Xrcc3 | X-ray repair complementing defective repair in Chinese hamster cells 3 | 2 | 2 | ||||||||
MIRT591614 | Vps37a | vacuolar protein sorting 37A | 2 | 2 | ||||||||
MIRT591708 | Rpusd2 | RNA pseudouridylate synthase domain containing 2 | 2 | 2 | ||||||||
MIRT591720 | Rorb | RAR-related orphan receptor beta | 2 | 2 | ||||||||
MIRT591740 | Rab9b | RAB9B, member RAS oncogene family | 2 | 4 | ||||||||
MIRT591815 | Mocs1 | molybdenum cofactor synthesis 1 | 2 | 2 | ||||||||
MIRT591838 | Lin7a | lin-7 homolog A (C. elegans) | 2 | 2 | ||||||||
MIRT591850 | Iglon5 | IgLON family member 5 | 2 | 2 | ||||||||
MIRT591897 | Fbrs | fibrosin | 2 | 2 | ||||||||
MIRT591978 | Ap1ar | adaptor-related protein complex 1 associated regulatory protein | 2 | 2 | ||||||||
MIRT592164 | Oxtr | oxytocin receptor | 2 | 2 | ||||||||
MIRT592241 | LOC100048884 | major urinary protein 18 | 2 | 2 | ||||||||
MIRT592285 | Gatc | glutamyl-tRNA(Gln) amidotransferase, subunit C | 2 | 2 | ||||||||
MIRT592450 | Ski | ski sarcoma viral oncogene homolog (avian) | 2 | 2 | ||||||||
MIRT592466 | Runx1 | runt related transcription factor 1 | 2 | 2 | ||||||||
MIRT592683 | Has2 | hyaluronan synthase 2 | 2 | 2 | ||||||||
MIRT592831 | Asb7 | ankyrin repeat and SOCS box-containing 7 | 2 | 2 | ||||||||
MIRT592853 | Akap2 | A kinase (PRKA) anchor protein 2 | 2 | 2 | ||||||||
MIRT593348 | Tmco1 | transmembrane and coiled-coil domains 1 | 2 | 2 | ||||||||
MIRT593391 | Adra1b | adrenergic receptor, alpha 1b | 2 | 2 | ||||||||
MIRT593402 | Znrf3 | zinc and ring finger 3 | 2 | 2 | ||||||||
MIRT593411 | Slc6a6 | solute carrier family 6 (neurotransmitter transporter, taurine), member 6 | 2 | 2 | ||||||||
MIRT593503 | Enpp4 | ectonucleotide pyrophosphatase/phosphodiesterase 4 | 2 | 2 | ||||||||
MIRT594179 | Vdr | vitamin D (1,25-dihydroxyvitamin D3) receptor | 2 | 2 | ||||||||
MIRT594723 | Zfp931 | zinc finger protein 931 | 2 | 2 | ||||||||
MIRT594918 | Gm14326 | predicted gene 14326 | 2 | 2 | ||||||||
MIRT594954 | Fblim1 | filamin binding LIM protein 1 | 2 | 2 | ||||||||
MIRT594996 | Tmem245 | transmembrane protein 245 | 1 | 1 | ||||||||
MIRT595717 | Calcr | calcitonin receptor | 2 | 2 | ||||||||
MIRT601211 | Arhgef9 | CDC42 guanine nucleotide exchange factor (GEF) 9 | 2 | 2 | ||||||||
MIRT604988 | Fsd1l | fibronectin type III and SPRY domain containing 1-like | 2 | 2 | ||||||||
MIRT605314 | Zfp92 | zinc finger protein 92 | 2 | 2 | ||||||||
MIRT605458 | St18 | suppression of tumorigenicity 18 | 2 | 2 | ||||||||
MIRT605538 | Pstpip2 | proline-serine-threonine phosphatase-interacting protein 2 | 2 | 2 | ||||||||
MIRT605601 | Nbeal1 | neurobeachin like 1 | 2 | 2 | ||||||||
MIRT605769 | Epas1 | endothelial PAS domain protein 1 | 2 | 2 | ||||||||
MIRT605937 | Sema6a | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 2 | 2 | ||||||||
MIRT605986 | Mylk4 | myosin light chain kinase family, member 4 | 2 | 2 | ||||||||
MIRT606188 | Slc5a8 | solute carrier family 5 (iodide transporter), member 8 | 2 | 2 | ||||||||
MIRT606238 | Rab3c | RAB3C, member RAS oncogene family | 2 | 2 | ||||||||
MIRT606736 | Tacr1 | tachykinin receptor 1 | 2 | 2 |